Determinants of Spike infectivity, processing, and neutralization in SARS-CoV-2 Omicron subvariants BA.1 and BA.2
This article has been Reviewed by the following groups
Discuss this preprint
Start a discussion What are Sciety discussions?Listed in
- Evaluated articles (ScreenIT)
Abstract
Article activity feed
-
-
SciScore for 10.1101/2022.04.13.488221: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Ethics Consent: Sera from vaccinated individuals: Blood samples of fully BNT162b2 vaccinated individuals were obtained after the participants information and written consent.
IRB: Ethics approval was provided by the Ethic Committee of Ulm University (vote 99/21–FSt/Sta).Sex as a biological variable not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Cell Line Authentication not detected. Table 2: Resources
Antibodies Sentences Resources Proteins were stained using primary antibodies directed against rabbit anti-V5 (Cell Signaling #13202; 1:1000), VSV-M (Absolute Antibody, 23H12, #Ab01404-2.0; 1:2000), actin (Anti-beta Actin antibody Abcam, ab8227, 1:5000,) and Infrared … SciScore for 10.1101/2022.04.13.488221: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Ethics Consent: Sera from vaccinated individuals: Blood samples of fully BNT162b2 vaccinated individuals were obtained after the participants information and written consent.
IRB: Ethics approval was provided by the Ethic Committee of Ulm University (vote 99/21–FSt/Sta).Sex as a biological variable not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Cell Line Authentication not detected. Table 2: Resources
Antibodies Sentences Resources Proteins were stained using primary antibodies directed against rabbit anti-V5 (Cell Signaling #13202; 1:1000), VSV-M (Absolute Antibody, 23H12, #Ab01404-2.0; 1:2000), actin (Anti-beta Actin antibody Abcam, ab8227, 1:5000,) and Infrared Dye labeled secondary antibodies (LI-COR IRDye anti-V5suggested: (Cell Signaling Technology Cat# 13202, RRID:AB_2687461)actinsuggested: (Abcam Cat# ab8227, RRID:AB_2305186)Anti-beta Actinsuggested: (Abcam Cat# ab8227, RRID:AB_2305186)ab8227suggested: NoneThereafter, samples were washed with PBS and incubated for 2 h at 4°C with primary antibody (anti-V5(MS) (1:1,000 MSsuggested: NoneThe samples were washed with PBS/0.1% Tween 20 and incubated in the dark for 2 h at 4°C with the secondary antibody (Alexa Fluor-647-conjugated anti-mouse antibody, 1:1000, Thermo Fisher Scientific) and 500 ng/ml DAPI. anti-mousesuggested: NoneExperimental Models: Cell Lines Sentences Resources Caco-2 (human epithelial colorectal adenocarcinoma) cells were cultivated in DMEM containing 10% FCS, 2mM glutamine, 100 μg/ml streptomycin and 100 U/ml penicillin, 1mM NEAA supplement. Caco-2suggested: NoneACE2 interaction assay: HEK293T cells expressing Spike were collected 48 h after the transfection, washed with phosphate-buffered saline (PBS), lysed in a non-denaturizing lysis buffer. HEK293Tsuggested: NoneRecombinant DNA Sentences Resources Expression Constructs: pCG_SARS-CoV-2-Spike-IRES_eGFP encoding the spike protein of SARS-CoV-2 isolate Wuhan-Hu-1(NCBI reference Sequence YP_009724390.1), pCG_SARS-CoV-2-S (1.617), pCG1_SARS-2-S (B.1.1.529) and pCG1_SARS-2-SΔ18 (BA.2) were kindly provided by Stefan Pöhlmann (DPZ Göppingen, Germany). pCG_SARS-CoV-2-Spike-IRES_eGFPsuggested: NonepCG_SARS-CoV-2-Ssuggested: NonepCG1_SARS-2-Ssuggested: NonepCG1_SARS-2-SΔ18suggested: NonepCG_SARS-CoV-2-Spike C-V5-IRES_eGFP was PCR amplified and subcloned into a pCG-IRES_eGFP expression construct using the restriction enzymes XbaI+MluI. pCG_SARS-CoV-2-Spike C-V5-IRES_eGFPsuggested: NoneACE2 was synthezised by Twist bioscience, PCR amplified, and subcloned into a pCG-IRES_eGFP expression construct using the restriction enzymes XbaI+MluI. pCG-IRES_eGFPsuggested: NoneSoftware and Algorithms Sentences Resources Twenty-four hours post-transfection, fluorescence microscopy images were acquired using the Cytation 3 microplate reader (BioTek Instruments) and the GFP area was quantified using ImageJ. ImageJsuggested: (ImageJ, RRID:SCR_003070)Statistical analysis: Statistical analyses were performed using GraphPad PRISM 9.2 (GraphPad Software). GraphPad PRISMsuggested: (GraphPad Prism, RRID:SCR_002798)GraphPadsuggested: (GraphPad Prism, RRID:SCR_002798)Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: We detected the following sentences addressing limitations in the study:Limitations of the study: In the present study, we used pseudotyped viral particles instead of replication-competent recombinant SARS-CoV-2 variants, which serves as a proxy to assess infectivity, fusion activity and incorporation. In addition, the impact of many changes might be context-dependent and this might explain why some individual changes had disruptive effects on Hu-1 S function although they are found in Omicron S proteins. It is difficult to predict which of the numerous mutations in the Omicron S might compensate for disruptive mutations. For example, we found that the BA.1 S was less effective in mediating infection than the BA.2 S protein (Figure 2). This agrees, with accumulating evidence that the BA.2 VOC might be more infectious and more virulent than the BA.1 VOC (Suzuki et al., 2022). In addition, we analysed only a limited number of sera from individuals who received a single vaccine regimen (BNT/BNT) and just a few therapeutic antibodies. While further studies are required to fully understand the full consequences of all the complex changes in the Omicron Spike on viral infectivity, tropism, transmission and pathogenesis our results provide first important insights into the functional impact of mutations characteristic for the Omicron VOC Spike that currently dominates the pandemic.
Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
Results from scite Reference Check: We found no unreliable references.
-
